Andrew Kucharchuk
Director of Finance/CFO at THERALINK TECHNOLOGIES, INC.
Net worth: 290 $ as of 2024-04-29
Andrew Kucharchuk active positions
| Companies | Position | Start | End |
|---|---|---|---|
| THERALINK TECHNOLOGIES, INC. | Director/Board Member | 2015-08-31 | - |
| Director of Finance/CFO | 2023-05-07 | - | |
| Investor Relations Contact | - | - | |
| Chief Executive Officer | 2019-11-07 | 2020-06-04 | |
| President | 2015-08-31 | 2020-06-04 | |
| AVANT DIAGNOSTICS INC | Director/Board Member | - | - |
| ADHERA THERAPEUTICS, INC. | Director/Board Member | 2022-05-18 | - |
| Chief Operating Officer | 2022-09-29 | - | |
| Chief Executive Officer | 2020-07-06 | 2022-09-29 | |
| Chairman | 2020-07-06 | 2022-05-18 | |
| CHAIN BRIDGE I | Director of Finance/CFO | 2024-03-31 | - |
| Kappa Alpha Order | Corporate Officer/Principal | - | - |
Career history of Andrew Kucharchuk
Former positions of Andrew Kucharchuk
| Companies | Position | Start | End |
|---|---|---|---|
OncBioMune, Inc.
 OncBioMune, Inc. BiotechnologyHealth Technology OncBioMune, Inc. develops biotechnologies for cancer treatment. The company is headquartered in Baton Rouge, LA. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - |
Training of Andrew Kucharchuk
| Louisiana State University | Undergraduate Degree |
| A.B. Freeman School of Business | Masters Business Admin |
Statistics
International
| United States | 9 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| Director of Finance/CFO | 3 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| THERALINK TECHNOLOGIES, INC. | Health Technology |
| CHAIN BRIDGE I | Finance |
| ADHERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Kappa Alpha Order | |
OncBioMune, Inc.
OncBioMune, Inc. BiotechnologyHealth Technology OncBioMune, Inc. develops biotechnologies for cancer treatment. The company is headquartered in Baton Rouge, LA. | Health Technology |
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
- Stock Market
- Insiders
- Andrew Kucharchuk
- Experience
